Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$81,933,833
+$45,072,227 QoQ
Shares Held
10,437,431
-1.2% QoQ
Ownership
3.40%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#3
of 150 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,664,878 across 342 Biotechnology names. ABCL ranks #27 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ABCL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,933,833 | 10,437,431 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,861,606 | 10,562,065 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,873,568 | 5,810,985 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,030,964 | 5,175,142 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,100,222 | 4,110,852 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,972,739 | 3,126,789 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,543,921 | 3,257,311 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,587,451 | 2,533,635 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,101,613 | 2,061,356 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,708,544 | 1,480,915 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,105,348 | 1,069,238 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,508,371 | 1,197,472 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,868,142 | 1,063,180 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,748,088 | 762,346 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,732,012 | 960,712 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,873,320 | 1,200,538 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,752,369 | 727,922 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,835,844 | 495,984 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,373,080 | 515,600 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,685,364 | 84,100 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,298,752 | 377,216 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,779,238 | 111,285 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||